About the STRI Phase 2 Clinical Trial (the "Study")
The Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial is an IRB-approved study (ClinicalTrials.gov NCT05046561) that measures the effectiveness of STRI Formula in treating COVID-19 symptoms.
The Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial is an IRB-approved study
(ClinicalTrials.gov NCT05046561) that measures the effectiveness of STRI Formula in treating COVID-19 symptoms.
Study Hypothesis:
STRI Formula Helps People With COVID-19 Get Better Faster in the STRI Phase 2 Clinical Trial.
What is STRI Formula?
STRI Formula is a combination of food-based ingredients (botanicals, vitamins, minerals, and protein) that has been specifically designed to combat SARS-CoV-2, the virus that causes COVID-19, in the STRI Phase 2 Clinical Trial.
How Can I Participate?
Sign up via the “Enroll” button to see if you can qualify. Qualifiying participants are eligible to receive up to $900 in compensation for participation in the Study.
ABOUT STRI FORMULA
What is STRI Formula Made Of?
STRI Formula contains a combination of 9 active food-based ingredients (protein, minerals, vitamins, and botanicals) that has been specifically created to combat SARS-CoV-2, the coronavirus that causes COVID-19, in the STRI Phase 2 Clinical Trial.
STUDY OVERSIGHT
Developed and Overseen by Medical Physicians
The STRI Phase 2 Clinical Trial is being overseen by the Data Monitoring Committee, which consists of a group of physicians and clinical researchers.
COST & COMPENSATION
Is there any cost?
Will I be Compensated?
No. There is no cost for you to participate in the Study.
You will be compensated for your participation. Compensation is determined based on the enrollment stage and the days participated in the clinical study.
GET STARTED
Join the fight against COVID-19.
Get in touch to see if you qualify for the
STRI Phase 2 Clinical Trial today.